Terminate | Jotup

Sinopec Shanghai Petrochemical Company Limited Intends to Deregister and Terminate Its Reporting Obligations Under the U.S. Securities Exchange Act of 1934

Retrieved on:

Wednesday, April 10, 2024

Terminate, Exchange, Finance, Form, Shanghai Stock Exchange, Stock exchange, ADS, News, Shanghai Petrochemical

Sinopec Shanghai Petrochemical Company Limited Intends to Deregister and Terminate Its Reporting Obligations Under the U.S. Securities Exchange Act of 1934

Key Points:

Sinopec Shanghai Petrochemical Company Limited Intends to Deregister and Terminate Its Reporting Obligations Under the U.S. Securities Exchange Act of 1934
SHANGHAI, CHINA / EQS NEWSWIRE / March 15, 2024 – Sinopec Shanghai Petrochemical Company Limited (the “Company”) (HKEX:00338)(SSE:600688) announced today that the Company intends to deregister with the United States Securities and Exchange Commission (the “SEC”) and terminate its reporting obligations under the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”).
Thereafter, all of the Company’s reporting obligations under the Exchange Act will be suspended unless the Form 15F is withdrawn or denied.
Deregistration and termination of the Company’s reporting obligations under the Exchange Act are expected to become effective 90 days after its filing of Form 15F.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.

Browning West Issues Letter to Gildan Activewear Shareholders Announcing Intent to Requisition Special Meeting to Reconstitute Board of Directors

Retrieved on:

Friday, December 29, 2023

Today, Browning West issued a letter to shareholders announcing its intent to requisition a Special Meeting of Gildan Shareholders (the “Special Meeting”) to provide shareholders an opportunity to reconstitute Gildan’s Board of Directors (the “Board”) by removing five incumbent directors and installing five highly qualified individuals: Michael Kneeland, Glenn Chamandy, Peter Lee, Karen Stuckey, and J.P. Towner.

Key Points:

Today, Browning West issued a letter to shareholders announcing its intent to requisition a Special Meeting of Gildan Shareholders (the “Special Meeting”) to provide shareholders an opportunity to reconstitute Gildan’s Board of Directors (the “Board”) by removing five incumbent directors and installing five highly qualified individuals: Michael Kneeland, Glenn Chamandy, Peter Lee, Karen Stuckey, and J.P. Towner.
Browning West is a significant and long-term shareholder of Gildan, with a beneficial ownership position of approximately 5.0% of the Company’s outstanding shares.
We expect that Mr. Kneeland and the re-constituted Board will reassess committee composition and reassign committee chair roles.
Gildan’s Board has demonstrated it is unwilling to act in the best interest of the Company and its shareholders.

Major Upgrade to Auto-Invest Bot: Portfolio Set to Begin a New Chapter

Retrieved on:

Thursday, September 14, 2023

SINGAPORE, Sept. 13, 2023 /PRNewswire/ -- Recently, the Bitget team upgraded the auto-invest bot and introduced a brand new Portfolio mode. Bitget adheres to the principle of "Trade smarter", aiming to create a more convenient, efficient, and intelligent trading environment for users. Helping users to make smarter and more professional investments or trading decisions, which offers them the potential for greater profit.

Key Points:

Understanding and using a Portfolio is of utmost importance for the average user who is seeking gains in the ever-changing crypto market.
Recognizing this market phenomenon, Bitget has launched a user-friendly smart Portfolio mode to help users navigate the crypto market with ease.
Comprehensiveness and Richness: Portfolio recommendations encompass a collection of assets from a single or multiple domains, providing users with diversified choices.
4.2 Head to Recommended Portfolio, and select the corresponding recommended card based on the Portfolio profile information and ROI.

Major Upgrade to Auto-Invest Bot: Portfolio Set to Begin a New Chapter

Retrieved on:

Thursday, September 14, 2023

SINGAPORE, Sept. 14, 2023 /PRNewswire/ -- Recently, the Bitget team upgraded the auto-invest bot and introduced a brand new Portfolio mode. Bitget adheres to the principle of "Trade smarter", aiming to create a more convenient, efficient, and intelligent trading environment for users. Helping users to make smarter and more professional investments or trading decisions, which offers them the potential for greater profit.

Key Points:

Understanding and using a Portfolio is of utmost importance for the average user who is seeking gains in the ever-changing crypto market.
Recognizing this market phenomenon, Bitget has launched a user-friendly smart Portfolio mode to help users navigate the crypto market with ease.
Comprehensiveness and Richness: Portfolio recommendations encompass a collection of assets from a single or multiple domains, providing users with diversified choices.
4.2 Head to Recommended Portfolio, and select the corresponding recommended card based on the Portfolio profile information and ROI.

LithiumBank Announces Intellectual Property License Agreement with G2L Greenview Resources Inc. for Direct Lithium Extraction Technology, Pilot Plant Testing and Commercialization

Retrieved on:

Monday, September 11, 2023

CALGARY, Alberta, Sept. 11, 2023 (GLOBE NEWSWIRE) -- LithiumBank Resources Corp. (TSX-V: LBNK) (OTCQX: LBNKF) (“LithiumBank'' or the “Company”) is pleased to announce it has entered into an intellectual property license agreement on September 8th 2023 (the “Agreement”) with G2L Greenview Resources Inc. (“G2L”), a subsidiary of Go2Lithium Inc., whereby G2L shall grant to the Company a license (the “License”) in Alberta and Saskatchewan for a full suite of continuous ion exchange technologies (the “Licensed Technology”). The Direct Lithium Extraction (“DLE”) technology will be used to extract lithium salts from enriched brines present at the Company’s lithium development projects.

Key Points:

This update will include the G2L test work results and the effects of the Canadian federal government incentive tax credits for lithium brine processing.
G2L will also provide the Company with access to a deployment-ready pilot plant that has been previously operating in Australia.
Modifications to the pilot plant are almost complete and it is expected to be shipped in October to Alberta.
“This licensing agreement with G2L provides LithiumBank with access to best-in-class direct lithium extraction technology that we expect to have a significant impact on the economics of our Alberta projects,” said Paul Matysek, Executive Chairman of LithiumBank.

Rain Oncology Provides Company Update and Outlines Strategic Priorities of Milademetan Clinical Programs

Retrieved on:

Tuesday, May 30, 2023

Workforce, Therapy, RAIN, MRCGP, MANTRA, CMO, Doctor of Philosophy, Terminate, MD, Patient, DD, Management, Pharmaceutical industry

The Company is focused on reducing its cash burn with the expectation to extend cash runway to year-end 2026.

Key Points:

The Company is focused on reducing its cash burn with the expectation to extend cash runway to year-end 2026.
“It is imperative we understand those outcomes before allocating further capital to the milademetan program, with corporate expenses to be greatly reduced to maximize optionality for Rain.
It was the tremendous effort of our Rain colleagues that allowed us to execute on MANTRA ahead of schedule despite the extreme pressures of the pandemic.
I want to sincerely thank every Rain colleague who has been impacted by this realignment.

G1 Therapeutics Announces Top Line Results from Pivotal Phase 3 Trial of Trilaciclib in Patients Receiving Triplet Therapy with FOLFOXIRI + Bevacizumab for Metastatic Colorectal Cancer (CRC) (PRESERVE 1)

Retrieved on:

Monday, February 13, 2023

Data monitoring committee, Terminate, Safety, RESEARCH, Patient, Bevacizumab, Therapy, Congress, FOLFOXIRI, ORR, Survival, CRC, DMC, Neutropenia, Medical imaging

RESEARCH TRIANGLE PARK, N.C., Feb. 13, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced topline results from its pivotal Phase 3 PRESERVE 1 trial showing that the trial achieved its co-primary endpoints related to severe neutropenia with statistical significance; however, early anti-tumor efficacy data, including overall response rate (ORR) and preliminary measures of survival, favored the placebo arm. Other clinical trials of trilaciclib in combination with different chemotherapies in patients with extensive-stage small cell lung cancer and triple negative breast cancer did not demonstrate this adverse survival signal. Given that placebo outperformed trilaciclib in these analyses of PRESERVE 1, the Company has made the decision to discontinue the colorectal (CRC) trial. The Data Monitoring Committee (DMC) has independently reached the same conclusion.

Key Points:

Given that placebo outperformed trilaciclib in these analyses of PRESERVE 1, the Company has made the decision to discontinue the colorectal (CRC) trial.
PRESERVE 1 was designed to evaluate the efficacy and safety of trilaciclib administered in addition to triplet therapy with FOLFOXIRI + bevacizumab in patients with metastatic CRC.
Detailed Phase 3 results will be presented at an upcoming scientific congress and submitted for publication.
“PRESERVE 1 is the first clinical evaluation of trilaciclib in a 5-FU-based chemotherapeutic backbone,” said Raj Malik, M.D., G1 Therapeutics’ Chief Medical Officer.

Corteva Agriscience to Host Virtual Roundtable on Cover Crop Termination Strategies

Retrieved on:

Tuesday, January 25, 2022

DuPont, Carbon, Crop protection, Practical Farmers of Iowa, Growth, Corteva, Soil, Farmer, Terminate, Kansas Department of Agriculture, Division of Water Resources, CST, Health, Industry, Agriculture, Risk, Confidence

Many farmers are seeking affordable alternatives to successfully terminate their cover crops and avoid additional risk on their operations.

Key Points:

Many farmers are seeking affordable alternatives to successfully terminate their cover crops and avoid additional risk on their operations.
Corteva's virtual roundtable is a timely event to help farmers tackle cover crop termination with confidence this year.
Corteva's panel of experts will review the timing and strategies around smart cover crop termination methods and explore alternative solutions to help farmers get the most out of their herbicide applications.
Corteva Agriscience became an independent public company on June 1, 2019 and was previously the Agriculture Division of DowDuPont.

Brooklyn Immuno Reports Inducement Grants

Retrieved on:

Friday, July 23, 2021

Labour law, Inheritance, Property law, Vesting, Terminate, Termination, Employment, Law, Private law, Articles

The unvested portion of the RSU and the Time-Based Option will terminate upon the termination of Mr. Sials employment with Brooklyn for any reason, subject to certain vesting acceleration provisions upon a qualifying termination, as described in his employment agreement with Brooklyn.

Key Points:

The unvested portion of the RSU and the Time-Based Option will terminate upon the termination of Mr. Sials employment with Brooklyn for any reason, subject to certain vesting acceleration provisions upon a qualifying termination, as described in his employment agreement with Brooklyn.
Both of the equity awards described above were granted pursuant to the Companys 2021 Inducement Stock Incentive Plan, which was not subject to stockholder approval.
Brooklyn is focused on exploring the role that cytokine, gene editing, and cell therapy can have in treating patients with cancer, blood disorders, and monogenic diseases.
For more information about Brooklyn and its clinical programs, please visit www.BrooklynITx.com.

Cable Modem Termination System Market Procurement Report | Roadmap to Recovery for Businesses From the Impact of COVID-19 Pandemic | SpendEdge

Retrieved on:

Wednesday, December 9, 2020

Networks, Internet, Hardware, Consumer electronics, Technology, Digital cable, Internet access, Modems, Internet protocols, Logical link control, Cable modem, Terminate, Telecommunications, Termination, Information and communications technology

The new Cable Modem Termination System market research report from SpendEdge indicates an incremental growth during the forecast period as the business impact of COVID-19 spreads.

Key Points:

The new Cable Modem Termination System market research report from SpendEdge indicates an incremental growth during the forecast period as the business impact of COVID-19 spreads.
View the full release here: https://www.businesswire.com/news/home/20201209005045/en/
SpendEdge has announced the release of its Global Cable Modem Termination System Market Procurement Intelligence Report (Graphic: Business Wire)
As the markets recover SpendEdge expects the Cable Modem Termination System market size to grow by USD 2.64 billion during the period 2020-2024.
Get detailed insights on the COVID-19 pandemic crisis and recovery analysis of the Cable Modem Termination System market.
Download free report sample
Analysis of the cost and volume drivers and supply market forecasts in various regions are offered in this Cable Modem Termination System research report.